E-therapeutics Plc
ETXPF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,869 | -$11,166 | -$8,274 | -$10,848 |
| Dep. & Amort. | $578 | $473 | $468 | $260 |
| Deferred Tax | $0 | $0 | -$1,157 | -$584 |
| Stock-Based Comp. | $36 | $78 | $155 | $490 |
| Change in WC | -$105 | -$162 | $123 | $425 |
| Other Non-Cash | -$2,199 | -$120 | $674 | -$161 |
| Operating Cash Flow | -$16,559 | -$10,897 | -$8,011 | -$10,419 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$410 | -$247 | -$68 | -$1,295 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$12,141 |
| Inv. Sales/Matur. | $0 | $0 | $15,051 | $0 |
| Other Inv. Act. | -$11,697 | $479 | $3,301 | -$9,835 |
| Investing Cash Flow | -$12,107 | $232 | $18,284 | -$13,436 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$393 | -$396 | $0 | $0 |
| Stock Issued | $0 | $0 | $13,437 | $21,669 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $28,913 | $37 | -$391 | $8,361 |
| Financing Cash Flow | $28,520 | -$359 | $13,046 | $30,030 |
| Forex Effect | $0 | $0 | -$1,279 | -$8,807 |
| Net Chg. in Cash | -$146 | -$11,024 | $20,343 | -$2,632 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,665 | $31,689 | $15,257 | $17,889 |
| End Cash | $20,519 | $20,665 | $39,041 | $15,257 |
| Free Cash Flow | -$16,969 | -$11,144 | -$8,221 | -$11,714 |